33 related articles for article (PubMed ID: 38564383)
1. Intralesional Triamcinolone Acetonide in the Treatment of Traction Alopecia.
Uwakwe LN; De Souza B; Tovar-Garza A; McMichael AJ
J Drugs Dermatol; 2020 Feb; 19(2):128-130. PubMed ID: 32129955
[TBL] [Abstract][Full Text] [Related]
2. Progressive hair loss.
Power DV; Disse M; Hordinsky M
J Fam Pract; 2017 Aug; 66(8):521-523. PubMed ID: 28783774
[TBL] [Abstract][Full Text] [Related]
3. Adalimumab-induced scalp psoriasis with severe alopecia.
Özkur E; Altunay İK; Leblebici C; Topkarcı Z; Erdem Y
Dermatol Ther; 2019 Sep; 32(5):e13033. PubMed ID: 31350777
[TBL] [Abstract][Full Text] [Related]
4. A new treatment of alopecia induced by palbociclib: Topical cetirizine.
Caro G; Fortuna MC; Magri F; Federico A; Carlesimo M; Rossi A
J Oncol Pharm Pract; 2021 Mar; 27(2):460-463. PubMed ID: 32529951
[TBL] [Abstract][Full Text] [Related]
5. Mitogen-Activated Protein Kinase Inhibitor-Induced Inflammatory Alopecia in Woman With Ovarian Cancer.
Rose L; Minta A; Plaza J; Cohn DE; Dulmage B
J Drugs Dermatol; 2024 Apr; 23(4):e102-e103. PubMed ID: 38564383
[TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of Minoxidil Treatment in Scarring Alopecia: A Scoping Review.
Ly N; McClure EM; Hordinsky MK; Farah RS; Park SY
J Drugs Dermatol; 2024 Mar; 23(3):146-151. PubMed ID: 38443124
[TBL] [Abstract][Full Text] [Related]
7. An Excellent Response to Tofacitinib in a Pediatric Alopecia Patient: A Case Report and Review.
Brown L; Skopit S
J Drugs Dermatol; 2018 Aug; 17(8):914-917. PubMed ID: 30124734
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Alopecia in Children.
Mishra P; Patil A; Sinclair R; Gold M; Rudnicka L; Grabbe S; Goldust M
J Drugs Dermatol; 2022 Jan; 21(1):49-53. PubMed ID: 35005859
[TBL] [Abstract][Full Text] [Related]
9. MEK1/2 inhibitors in the treatment of gynecologic malignancies.
Miller CR; Oliver KE; Farley JH
Gynecol Oncol; 2014 Apr; 133(1):128-37. PubMed ID: 24434059
[TBL] [Abstract][Full Text] [Related]
10. Potential drug-drug interactions with mitogen-activated protein kinase (MEK) inhibitors used to treat melanoma.
Marani A; Gioacchini H; Paolinelli M; Offidani A; Campanati A
Expert Opin Drug Metab Toxicol; 2023; 19(8):555-567. PubMed ID: 37659065
[TBL] [Abstract][Full Text] [Related]
11. Ocular Toxicity in Metastatic Melanoma Patients Treated With Mitogen-Activated Protein Kinase Kinase Inhibitors: A Case Series.
Niro A; Strippoli S; Alessio G; Sborgia L; Recchimurzo N; Guida M
Am J Ophthalmol; 2015 Nov; 160(5):959-967.e1. PubMed ID: 26231307
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
